Stock disconnect triggers investor exodus from CStone Pharma
基石藥業頻售產品權益 遭剔出港股通股價跳水

The share price fell nearly 40% in a week after the drugs company was dropped from a scheme allowing mainland investors to trade Hong Kong-listed stocks.
基石藥業被剔出港股通證券名單後，內地投資者紛紛拋售手中持股，導致其一週內的股價累計下跌近四成。